Investigating the Convergent Mechanisms between Major Depressive Disorder and Parkinson's Disease

Angela A Tran1,2, Myra De Smet1, Gary D Grant3

  • 1School of Medical Science, Griffith University, Southport, Queensland, Australia.

Complex Psychiatry
|December 9, 2021
PubMed

Insights

Major depressive disorder (MDD) and Parkinson's disease (PD) share overlapping neuroinflammatory pathways. Glial cells, particularly microglia and astrocytes, are key players in the pathophysiology of both conditions, influencing neurodegeneration and protein aggregate clearance.

Area of Science:

  • Neuroscience
  • Neuroinflammation
  • Neurodegenerative Diseases

Background:

  • Major depressive disorder (MDD) and Parkinson's disease (PD) exhibit a temporal relationship, suggesting shared underlying mechanisms.
  • Microglia and astrocytes are implicated in the pathophysiology of both MDD and PD, acting as crucial mediators.
  • Existing epidemiological and clinical studies support the association between MDD and PD, yet the precise mechanisms remain elusive.

Purpose of the Study:

  • To review and examine the overlapping pathophysiology of MDD and PD.
  • To elucidate the specific roles of glial cells (microglia and astrocytes) in the shared disease mechanisms.
  • To highlight the contribution of neuroinflammation to the progression of both MDD and PD.

Main Methods:

  • Review of existing scientific literature focusing on MDD, PD, glial cell function, and neuroinflammation.
  • Analysis of research investigating the activation of microglia and astrocytes in response to α-synuclein and peripheral inflammatory agents.
  • Examination of studies on the impact of neuroinflammation on monoamine transport, the hypothalamus-pituitary axis, neurogenesis, and glymphatic clearance.

Main Results:

  • Activated microglia and astrocytes in PD release cytokines triggered by α-synuclein, contributing to depressive symptoms.
  • Neuroinflammation in MDD, induced by inflammatory agents or neuronal signaling, can lead to neurodegeneration and exacerbate PD pathology.
  • Astrocytic dysfunction in MDD may impair glymphatic clearance, potentially facilitating α-synuclein aggregate accumulation in PD.

Conclusions:

  • Glial cell activation and neuroinflammation represent a significant link in the shared pathophysiology of MDD and PD.
  • Dysfunctional glymphatic clearance due to astrocytic issues in MDD could play a role in PD pathogenesis.
  • Further research into these overlapping mechanisms is crucial for developing effective therapeutic strategies for both conditions.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
436
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
814
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
181
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
422
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
234
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.5K